MOTS-c, AOD9604, and NAD+: Sourcing Notes for Mitochondrial-Metabolism Research
How research buyers should qualify MOTS-c, AOD9604, NAD+, and adjacent metabolic-research items without turning supplier content into unsupported treatment claims.
Published May 28, 2026 · 6 min read · By PeptideXpo Regulatory Team
MOTS-c, AOD9604, and NAD+ often appear in the same sourcing conversation because buyers group them under mitochondrial metabolism, energy metabolism, lipid metabolism, or longevity-adjacent research. That grouping is commercially useful, but chemically it is mixed. MOTS-c and AOD9604 are peptide products. NAD+ is a coenzyme, not a peptide, and should be qualified with the right analytical expectations.
How should buyers source MOTS-c, AOD9604, and NAD+ for metabolic research?
Buyers should source MOTS-c, AOD9604, and NAD+ by separating molecule class, analytical method, purity claim, storage condition, and release documentation. MOTS-c and AOD9604 require peptide-style COA, HPLC, MS identity, water, and sequence confirmation when needed. NAD+ requires coenzyme-specific identity and purity evidence. Do not accept broad "anti-aging" or "weight-loss" claims as supplier qualification.
Molecule-by-molecule sourcing posture
| Item | Sourcing category | First document to request |
|---|---|---|
| MOTS-c | Mitochondrial-derived peptide research | COA + HPLC + MS identity + sequence evidence if first qualification |
| AOD9604 | GH-fragment / lipid-metabolism research peptide | COA + HPLC + MS identity + water and counter-ion status |
| NAD+ | Coenzyme, not peptide | COA + identity assay + purity method + storage guidance |
| SS-31 | Mitochondrial-targeted peptide research | COA + HPLC + MS identity + salt-form detail |
Buyer risks to control
- Overbroad claims: Supplier pages should not claim diabetes treatment, guaranteed weight loss, or anti-aging outcomes. They should describe research category and documentation.
- Mixed analytical standards: A peptide COA is not the same as a coenzyme COA. NAD+ should not be treated as a peptide just because it appears in the same buyer basket.
- Unclear salt and water status: Peptides in metabolic research workflows often need water, counter-ion, and storage data to support reproducibility.
- No lot tie-back: Documents should belong to the exact lot offered, not a representative marketing packet.
What PeptideXpo can document
For peptide products, PeptideXpo can provide batch-specific COA, HPLC chromatogram, MS identity report, storage guidance, fill-size confirmation, and add-on tests when the buyer specifies route or pathway needs. For NAD+ and adjacent non-peptide items, the release packet should use the identity and purity methods appropriate to that molecule class rather than borrowing peptide language.
Talk to our regulatory team
Need metabolic-research products with lot documentation?
Tell us whether you need MOTS-c, AOD9604, NAD+, SS-31, or a related product list. We will confirm molecule class and release-packet scope.